Riaz Khan

Riaz Khan

Auto-generated profile, based on publicly available information

Riaz Khan

Rumsey, Berkshire, England, United Kingdom

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1996 in Australian Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
RKR Khan
R Khan
PKPa Konowicz
Pa Konowicz
LGLucia Gardossi
Lucia Gardossi
MMMaria Matulova
Maria Matulova
SDS Degennaro
S Degennaro
Selective deacetylation reactions of the peracetylated reducing disaccharides (1), (5), (9), (15), ß-D- glucopyranose (17) and 2-acetamido-2-deoxy-ß-D-glucopyranose (19), with 1.2 equiv. Of hydrazine hydrate in acetonitrile, gave predominantly the corresponding heptaacetates (2), (6), (10), (16), the tetraacetate (18) and the triacetate (20), with the free hydroxy group at C1. Reaction of (1) with 1.2 equiv. of hydrazine hydrate in N,N- dimethylformamide also afforded the heptaacetate (2), but in lower yield. When reactions of (1), (5) and (9) were performed with 2.5 equiv. of hydrazine hydrate, deacetylation also occurred at other positions to afford the corresponding hexaacetates (3), (7), (11) and (12), with hydroxy groups at C 1,2 or C 1,3, and the pentaacetates (4), (8) and (13), with hydroxy groups at C 1,2,3. Maltose octaacetate (9), in addition, yielded the tetraacetate (14) in which the free hydroxy groups were located at C1,2,2',3. Compound (15) on treatment with 2.5 equiv. of hydrazine hydrate afforded an intractable mixture. The reaction of methyl 2,3,4,6-tetra-O-acetyl-a-D-glucopyranoside (21) with 2.5 equiv. of hydrazine hydrate gave the 3,4,6-triacetate (22), a mixture of the 2,6- and the 3,6-diacetates (23) and (24), respectively, the 4,6-diacetate (25), and the 6-acetate (26).

16 March 2022 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
TRThirumalaisamy Rathinavel
Thirumalaisamy Rathinavel
VINCENT AROULMOJIVINCENT AROULMOJI
VINCENT AROULMOJI
MIMuhammad Nasir Iqbal
Muhammad Nasir Iqbal
SSShreyas Saride
Shreyas Saride
MBM. Bhuvaneswari
M. Bhuvaneswari
RKRiaz Khan
Riaz Khan
The present study examines cellular targeted drug delivery (CTDD) pattern of two novel Hyaluronic acid (HA) Tuberculosis Drug (TB) conjugates and its efficacy and strong binding affinity towards TB molecular protein targets. Two TB drugs ethambutol (EB) and isoniazid (IN) and their Hyaluronic acid conjugates (HA-EB & HA-IN) were tested for its metabolism, toxicity and excretion prediction through In silico tools they revealed hyaluronic acid conjugate of two TB drugs exhibited good drug profile over their free form of TB drugs. Further these four molecules subjected to In silico molecular docking study with four potential Mycobacterium tuberculosis target proteins (3PD8, 4Y0L, 5DZK and 6GAU). Molecular docking study revealed that hyaluronic conjugates (HA-EB & HA-IN) exhibit significant binding affinity and excellent docking scores with all screened molecular protein targets of TB over their free form of drug. Further molecular dynamic simulation was calculated for the four drug molecules (EB, IN, HA- EB & HA-IN) with DNA gyrase enzyme (PDB ID 6GAU) of Mycobacterium tuberculosis and the MDS results revealed that both the conjugates with the TB target protein possessed good number of interaction with binding pocket residues and good simulation scores than the free form of drugs. Communicated by Ramaswamy H. Sarma